Roche ACCU-CHEK Inform II Manual do Utilizador descarregar pdf (Página 52)

Recommended NICE guidelines for self –monitoring

• Type 1 diabetes

The majority of people with Type 1 diabetes in hospital need to monitor their blood glucose levels 4 – 6 times a day (pre

and post meals), before bed and occasionally overnight. More frequent monitoring during illness or changes in treatment

may be required. e.g. hourly if on an insulin infusion

• Type 1 diabetes on insulin infusion pump

Those using an insulin pump are advised monitor their blood glucose at least 6 times a day. More frequent during illness

or changes in treatment

• Pre –pregnancy and pregnancy with diabetes

Monitoring is recommended 6 times a day (pre and 2 hr post meals), to manage and achieve optimal diabetes control to

avoid complications pre-conception and during pregnancy.

• Type 2 diabetes – on insulin

People with Type 2 diabetes on multiple daily insulin injections are advised to monitor as those with Type 1 diabetes.

Those with Type 2 on twice daily insulin should be supported to provide a profile varying the times between fasting, pre-

meal and post-meal to identify trends

Fasting blood glucose should be monitored daily during basal insulin dose titrations.

• Type 2 diabetes – on oral hypoglycaemic agents

Monitoring is needed to reveal if hyperglycaemia or hypoglycaemia is being experienced and if medication needs altering

for by those using sulphonylureas or combination therapy

Those with Type 2 on twice daily insulin should be monitored to provide a profile varying the times between fasting, pre-

meal and post-meal and bedtime to identify trends and inform treatment plans.

• Type 2 diabetes – Healthy eating and physical activity with or without Metformin

Monitoring would be required to assess stress related hyperglycaemia. A HbA1c is useful here to guide future

treatment.

1 2 ... 47 48 49 50 51 52 53 54 55 56 57 58 59

Sem comentários

Roche ACCU-CHEK Inform II Manual do Utilizador Página 52